Ascentage Pharma (AAPG) began trading on the Nasdaq on 24 Jan 25

Ascentage Pharma Group International Co., Ltd. is a clinical-stage biotechnology company. It engages in the development of novel therapies for cancers, hepatitis B virus, or HBV, and age-related diseases. 

• Founded by Da Jun Yang, Wang Shao Meng and Ming Guo in May 2009 
• Headquartered in Suzhou, China.
• Website: ascentage.cn
• Employees: 567

Ticker:  AAPG

Ascentage Pharma has been listed on the Main Board of the Stock Exchange of Hong Kong Limited with the stock code 6855.HK since October 2019